Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases

NCT01697371 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT01697371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01697371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases
Lead sponsor
Loma Linda University
Phase
Not applicable
Overall status
Recruiting
Start date
August 22, 2012
Completion date
September 30, 2033
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastases